Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CGI Pharmaceuticals, Inc. logo — company profile

CGI Pharmaceuticals, Inc.

Founded 1998 United States Branford, United States 11 employees Series C Total: $44.30M Biotechnology, Health Care +1

General Information

Company Name CGI Pharmaceuticals, Inc.
Founded Year 1998
Location United States Branford, United States
Employees 11
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with CGI Pharmaceuticals, Inc.. To contact CGI Pharmaceuticals, Inc., visit cgipharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CGI Pharmaceuticals, Inc. compare?

A PDF of CGI Pharmaceuticals, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CGI Pharmaceuticals, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CGI Pharmaceuticals, Inc.

CGI Pharmaceuticals, Inc. was a venture-backed kinase drug discovery company founded in 1998 out of Yale University. The company operated in the Biotechnology, Health Care, and Pharmaceutical industries and was headquartered in the United States. CGI received a significant $22.30M Series C investment on 21 January 2004, with funding from notable investors such as Connecticut Innovations, MPM Capital, Flagship Pioneering, Emerging Technologies Partners, Lilly Ventures, Vector Fund Management, and Coastview Capital. In July 2010, CGI Pharmaceuticals was acquired by Gilead Sciences. Despite the acquisition, CGI's research laboratories in Branford, Connecticut continued to operate under Gilead, Connecticut. This acquisition marked a significant development in the company's journey, potentially providing opportunities for further growth and expansion within the pharmaceutical and biotechnology sectors.

Business keywords: Pharmaceuticals, Drug discovery, Kinase, Yale University, Biotech, Chemical genetics, Oncology, Autoimmune disease, Inflammatory disease, Small molecule therapeutics, Patents, Drug metabolism, Pharmacokinetics, Chemistry capabilities

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $22.30M 7
Connecticut Innovations MPM Capital Flagship Pioneering
Connecticut Innovations, MPM Capital +5
21 Jan 2004
Series B $22.00M -
02 Jan 2001

CGI Pharmaceuticals, Inc. Alternatives & Competitors

View All Alternatives
CGI Pharmaceuticals, Inc. vs
HepatoChem
HepatoChem United States

Reinventing Chemistry for Life Sciences

Debt Financing
8 employees
Biotechnology, Information Technology
CGI Pharmaceuticals, Inc. vs
IpiNovyx Bio
IpiNovyx Bio United States

We are a drug platform focused on treating autoimmune and inflammatory diseases.

Seed
6 employees
Biopharma, Biotechnology
CGI Pharmaceuticals, Inc. vs
Tyligand Bioscience
Tyligand Bioscience

Innovative small molecule therapeutics for cancer and autoimmune disease treatment.

Series A
4 employees
Biotechnology, Health Care
View all alternatives

FAQ About CGI Pharmaceuticals, Inc.

CGI Pharmaceuticals was a venture-backed kinase drug discovery company. Founded out of Yale University in 2000, CGI was acquired by Gilead Sciences in July 2010. CGI's research laboratories (located in Branford, Connecticut) continue to operate as Gilead, Connecticut.
CGI Pharmaceuticals, Inc. was founded in 1998.
CGI Pharmaceuticals, Inc. is headquartered in Branford, United States.
CGI Pharmaceuticals, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Pharmaceuticals, Drug discovery, Kinase and Yale University.
CGI Pharmaceuticals, Inc. has approximately 11 employees.
CGI Pharmaceuticals, Inc. has completed 2 funding rounds, raising a total of $44.30M. The latest funding stage is Series C.
Top alternatives and competitors to CGI Pharmaceuticals, Inc. include HepatoChem, IpiNovyx Bio, Tyligand Bioscience, Vividion Therapeutics, Inc., BlossomHill Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CGI Pharmaceuticals, Inc. and HepatoChem are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CGI Pharmaceuticals, Inc., https://bouncewatch.com/company/cgi-pharmaceuticals-inc, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes